Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seokhyeong Go

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Advanced Materials (Deerfield Beach, Fla.)|September 12, 2021
Nanocomplex-Mediated In Vivo Programming to Chimeric Antigen Receptor-M1 Macrophages for Cancer TherapyMikyung Kang, Seong Ho Lee, Miji Kwon, et al.
Frontiers in Immunology|June 15, 2026
High-dimensional immune profiling of peripheral blood identifies immune correlates of anti-PD-1/PD-L1 resistance in oncogenic driver mutation-positive NSCLCKyoo Hyun Kim, Mina Han, Geon Woo Park, et al.
Cell Reports. Medicine|October 4, 2025
4-1BB<sup>+</sup> Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapyJunha Cha, Chang Gon Kim, Nam Suk Sim, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Advanced Materials (Deerfield Beach, Fla.)|September 12, 2021
Nanocomplex-Mediated In Vivo Programming to Chimeric Antigen Receptor-M1 Macrophages for Cancer TherapyMikyung Kang, Seong Ho Lee, Miji Kwon, et al.
Frontiers in Immunology|June 15, 2026
High-dimensional immune profiling of peripheral blood identifies immune correlates of anti-PD-1/PD-L1 resistance in oncogenic driver mutation-positive NSCLCKyoo Hyun Kim, Mina Han, Geon Woo Park, et al.
Cell Reports. Medicine|October 4, 2025
4-1BB<sup>+</sup> Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapyJunha Cha, Chang Gon Kim, Nam Suk Sim, et al.
Pageof 2